Cargando…

Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade I

BACKGROUND: Prognostic markers for meningioma recurrence are needed to guide patient management. Apart from rare hereditary syndromes, the impact of a previous unrelated tumor disease on meningioma recurrence has not been described before. METHODS: We retrospectively searched our database for patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Biczok, Annamaria, Karschnia, Philipp, Vitalini, Raffaela, Lenski, Markus, Greve, Tobias, Thorsteinsdottir, Jun, Egensperger, Rupert, Dorn, Franziska, Tonn, Jörg-Christian, Schichor, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437882/
https://www.ncbi.nlm.nih.gov/pubmed/33674888
http://dx.doi.org/10.1007/s00701-021-04780-9
_version_ 1783752249201131520
author Biczok, Annamaria
Karschnia, Philipp
Vitalini, Raffaela
Lenski, Markus
Greve, Tobias
Thorsteinsdottir, Jun
Egensperger, Rupert
Dorn, Franziska
Tonn, Jörg-Christian
Schichor, Christian
author_facet Biczok, Annamaria
Karschnia, Philipp
Vitalini, Raffaela
Lenski, Markus
Greve, Tobias
Thorsteinsdottir, Jun
Egensperger, Rupert
Dorn, Franziska
Tonn, Jörg-Christian
Schichor, Christian
author_sort Biczok, Annamaria
collection PubMed
description BACKGROUND: Prognostic markers for meningioma recurrence are needed to guide patient management. Apart from rare hereditary syndromes, the impact of a previous unrelated tumor disease on meningioma recurrence has not been described before. METHODS: We retrospectively searched our database for patients with meningioma WHO grade I and complete resection provided between 2002 and 2016. Demographical, clinical, pathological, and outcome data were recorded. The following covariates were included in the statistical model: age, sex, clinical history of unrelated tumor disease, and localization (skull base vs. convexity). Particular interest was paid to the patients’ past medical history. The study endpoint was date of tumor recurrence on imaging. Prognostic factors were obtained from multivariate proportional hazards models. RESULTS: Out of 976 meningioma patients diagnosed with a meningioma WHO grade I, 416 patients fulfilled our inclusion criteria. We encountered 305 women and 111 men with a median age of 57 years (range: 21–89 years). Forty-six patients suffered from a tumor other than meningioma, and no TERT mutation was detected in these patients. There were no differences between patients with and without a positive oncological history in terms of age, tumor localization, or mitotic cell count. Clinical history of prior tumors other than meningioma showed the strongest association with meningioma recurrence (p = 0.004, HR = 3.113, CI = 1.431–6.771) both on uni- and multivariate analysis. CONCLUSION: Past medical history of tumors other than meningioma might be associated with an increased risk of meningioma recurrence. A detailed pre-surgical history might help to identify patients at risk for early recurrence.
format Online
Article
Text
id pubmed-8437882
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-84378822021-09-29 Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade I Biczok, Annamaria Karschnia, Philipp Vitalini, Raffaela Lenski, Markus Greve, Tobias Thorsteinsdottir, Jun Egensperger, Rupert Dorn, Franziska Tonn, Jörg-Christian Schichor, Christian Acta Neurochir (Wien) Original Article - Tumor - Meningioma BACKGROUND: Prognostic markers for meningioma recurrence are needed to guide patient management. Apart from rare hereditary syndromes, the impact of a previous unrelated tumor disease on meningioma recurrence has not been described before. METHODS: We retrospectively searched our database for patients with meningioma WHO grade I and complete resection provided between 2002 and 2016. Demographical, clinical, pathological, and outcome data were recorded. The following covariates were included in the statistical model: age, sex, clinical history of unrelated tumor disease, and localization (skull base vs. convexity). Particular interest was paid to the patients’ past medical history. The study endpoint was date of tumor recurrence on imaging. Prognostic factors were obtained from multivariate proportional hazards models. RESULTS: Out of 976 meningioma patients diagnosed with a meningioma WHO grade I, 416 patients fulfilled our inclusion criteria. We encountered 305 women and 111 men with a median age of 57 years (range: 21–89 years). Forty-six patients suffered from a tumor other than meningioma, and no TERT mutation was detected in these patients. There were no differences between patients with and without a positive oncological history in terms of age, tumor localization, or mitotic cell count. Clinical history of prior tumors other than meningioma showed the strongest association with meningioma recurrence (p = 0.004, HR = 3.113, CI = 1.431–6.771) both on uni- and multivariate analysis. CONCLUSION: Past medical history of tumors other than meningioma might be associated with an increased risk of meningioma recurrence. A detailed pre-surgical history might help to identify patients at risk for early recurrence. Springer Vienna 2021-03-05 2021 /pmc/articles/PMC8437882/ /pubmed/33674888 http://dx.doi.org/10.1007/s00701-021-04780-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article - Tumor - Meningioma
Biczok, Annamaria
Karschnia, Philipp
Vitalini, Raffaela
Lenski, Markus
Greve, Tobias
Thorsteinsdottir, Jun
Egensperger, Rupert
Dorn, Franziska
Tonn, Jörg-Christian
Schichor, Christian
Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade I
title Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade I
title_full Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade I
title_fullStr Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade I
title_full_unstemmed Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade I
title_short Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade I
title_sort past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas who grade i
topic Original Article - Tumor - Meningioma
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437882/
https://www.ncbi.nlm.nih.gov/pubmed/33674888
http://dx.doi.org/10.1007/s00701-021-04780-9
work_keys_str_mv AT biczokannamaria pastmedicalhistoryoftumorsotherthanmeningiomaisanegativeprognosticfactorfortumorrecurrenceinmeningiomaswhogradei
AT karschniaphilipp pastmedicalhistoryoftumorsotherthanmeningiomaisanegativeprognosticfactorfortumorrecurrenceinmeningiomaswhogradei
AT vitaliniraffaela pastmedicalhistoryoftumorsotherthanmeningiomaisanegativeprognosticfactorfortumorrecurrenceinmeningiomaswhogradei
AT lenskimarkus pastmedicalhistoryoftumorsotherthanmeningiomaisanegativeprognosticfactorfortumorrecurrenceinmeningiomaswhogradei
AT grevetobias pastmedicalhistoryoftumorsotherthanmeningiomaisanegativeprognosticfactorfortumorrecurrenceinmeningiomaswhogradei
AT thorsteinsdottirjun pastmedicalhistoryoftumorsotherthanmeningiomaisanegativeprognosticfactorfortumorrecurrenceinmeningiomaswhogradei
AT egenspergerrupert pastmedicalhistoryoftumorsotherthanmeningiomaisanegativeprognosticfactorfortumorrecurrenceinmeningiomaswhogradei
AT dornfranziska pastmedicalhistoryoftumorsotherthanmeningiomaisanegativeprognosticfactorfortumorrecurrenceinmeningiomaswhogradei
AT tonnjorgchristian pastmedicalhistoryoftumorsotherthanmeningiomaisanegativeprognosticfactorfortumorrecurrenceinmeningiomaswhogradei
AT schichorchristian pastmedicalhistoryoftumorsotherthanmeningiomaisanegativeprognosticfactorfortumorrecurrenceinmeningiomaswhogradei